Overview

Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer

Status:
Suspended
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
Phase III study that aims to evaluate the necessity of prophylactic antibiotics use after HDR brachytherapy in the treatment of prostate adenocarcinomas.
Phase:
Phase 3
Details
Lead Sponsor:
CR-CSSS Champlain-Charles-Le Moyne
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Cefazolin
Ciprofloxacin